Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

KB801 - Phase 2 | KRYS Pipeline | CatalystAlert

KB801

Phase 2

Krystal Biotech, Inc. (KRYS)

16%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Dec 2025~

KRYSPhase 2Phase 2

KB801 Phase 2 Results Expected

KB801 • Neurotrophic Keratitis

Drug Information

Target Indication

Neurotrophic Keratitis

Clinical Trial

Last updated: 12/4/2025

Developer

KRYS

Krystal Biotech, Inc.

Biotechnology•North America•NASDAQ